| Line Item | 2022-10-01 | Y/Y |
|---|---|---|
| Revenue | $800.6M | +17.1% |
| Cost of Revenue | $764.1M | +24.9% |
| Gross Profit | $36.5M | -49.3% |
| R&D Expense | $6.1M | +17.3% |
| SG&A Expense | $77.2M | +17.7% |
| Operating Income | -$40.7M | -724.0% |
| Interest Expense | $14.7M | +51.6% |
| Pre-tax Income | -$53.1M | -2582.1% |
| Income Tax | -$11.5M |
| Line Item | 2022-10-01 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.5M | -10.5% |
| Accounts Receivable | $12.5M | +25.8% |
| Inventory | $143.0M | +14.2% |
| Current Assets | $174.5M | +11.8% |
| Total Assets | $366.1M | +2.8% |
| Current Liabilities | $164.8M | +32.0% |
| Long-term Debt | $130.4M | -12.8% |
| Line Item | 2022-10-01 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.4M | +54.9% |
| Investing Cash Flow | -$6.5M | +42.9% |
| Financing Cash Flow | $29.7M | -9.4% |
| -861.5% |
| Net Income | -$45.8M | — |
| EPS (Basic) | -$1.48 | — |
| EPS (Diluted) | -$1.48 | — |
| Stockholders' Equity |
| $1.4M |
| +104.2% |